Drug profile · INN
azithromycin dihydrate
TROVAN/ZITHROMAX COMPLIANCE PAK
azithromycin dihydrate (TROVAN/ZITHROMAX COMPLIANCE PAK) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — azithromycin dihydrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
azithromycin dihydrate (TROVAN/ZITHROMAX COMPLIANCE PAK) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Congress & event coverage
- PresentationTHMA Pharmacy Growth
Related & competitor drugs
Frequently asked questions
What is azithromycin dihydrate?
azithromycin dihydrate (TROVAN/ZITHROMAX COMPLIANCE PAK) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for azithromycin dihydrate?
TROVAN/ZITHROMAX COMPLIANCE PAK is a marketed brand name for azithromycin dihydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of azithromycin dihydrate?
azithromycin dihydrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.